Article info
PDFOriginal research
Improving the management of early colorectal cancers (eCRC) by using quantitative markers to predict lymph node involvement and thus the need for major resection of pT1 cancers
- Correspondence to Dr Scarlet Brockmoeller, Leeds Institute of Cancer & Pathology, University of Leeds, Leeds LS2 9JT, UK; S.F.Brockmoeller{at}leeds.ac.uk
Citation
Improving the management of early colorectal cancers (eCRC) by using quantitative markers to predict lymph node involvement and thus the need for major resection of pT1 cancers
Publication history
- Received February 11, 2021
- Revised March 12, 2021
- Accepted March 18, 2021
- First published October 13, 2021.
Online issue publication
July 19, 2022
Article Versions
- Previous version (13 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.